Phase II Clinical Trial of Stereotactic Ablative Radiotherapy (SABR) in Surgically Operable Stage I Non-Small Cell Lung Cancer (STARS)

被引：0
|
作者：
Chang, Joe Y. [1 ]
Mehran, Reza [2 ]
Balter, Peter [1 ]
Mcrae, Stephen [3 ]
Feng, Lei [4 ]
Berry, Donald [4 ]
Komaki, Ritsuko U. [1 ]
Roth, Jack [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Thorac Surg, Houston, AL USA
[3] Univ Texas MD Anderson Canc Ctr, Radiol, Houston, AL USA
[4] Univ Texas MD Anderson Canc Ctr, Biostat, Houston, AL USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
operable Stage I lung cancer; stereotactic radiotherapy; SBRT; SABR;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.02-032
引用
收藏
页码：S563 / S563
页数：1
相关论文
共 50 条
  • [21] Stereotactic ablative radiotherapy with nivolumab for early-stage operable non-small cell lung cancer: A phase 2 study.
    Schvartsman, Gustavo
    Pires de Rezende, Ana Carolina
    Diniz Gomes, Diogo Bugano
    Koch, Ludmila De Oliveira
    Bibas, Benoit Jacques
    Gomes, Oswaldo
    Campregher, Paulo V.
    Severino, Patricia
    Marti, Luciana Cavalheiro
    Paes, Vitor Ribeiro
    Chate, Rodrigo Caruso
    Ribas, Jose Milanez
    Ramos Sousa, Victor Aurelio
    Taranto, Patricia
    Moura, Fernando
    Terra, Ricardo Mingarini
    Samano, Marcos Naoyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer
    Koto, Masashi
    Takai, Yoshihiro
    Ogawa, Yoshihiro
    Matsushita, Haruo
    Takeda, Ken
    Takahashi, Chiaki
    Britton, Keith R.
    Jingu, Kei-ichi
    Takai, Kenji
    Mitsuya, Masatoshi
    Nemoto, Kenji
    Yamada, Shogo
    RADIOTHERAPY AND ONCOLOGY, 2007, 85 (03) : 429 - 434
  • [23] A phase I/II study on stereotactic body radiotherapy for stage I non-small cell lung cancer
    Koto, M.
    Takai, Y.
    Ogawa, Y.
    Ariga, H.
    Takeda, K.
    Sakayauchi, T.
    Narasaki, K.
    Jingu, K.
    Yamada, S.
    EJC SUPPLEMENTS, 2007, 5 (04): : 380 - 380
  • [24] Stereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard
    Yalman, Deniz
    Selek, Ugur
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (11)
  • [25] To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer
    Shultz, David Benjamin
    Diehn, Maximilian
    Loo, Billy W., Jr.
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (02) : 78 - 86
  • [26] Stereotactic Ablative Radiotherapy in Clinical Stage I (< 5cm) Non-Small Cell Lung Cancer
    Ahn, S. J.
    Jeon, W.
    Kim, Y. C.
    Oh, I. J.
    Jeong, J. U.
    Yoon, M. S.
    Song, J. Y.
    Nam, T. K.
    Chung, W. K.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S655 - S656
  • [27] Stereotactic Ablative Radiotherapy for stage I non-small cell lung cancer: retrospective observational study
    Pieri, M.
    Cima, S.
    Capuccini, J.
    Labropoulos, F.
    Palombarini, M.
    Salvi, F.
    Compagnone, G.
    Deodato, F.
    Morganti, A. G.
    Frezza, G.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S636 - S636
  • [28] STEREOTACTIC BODY ABLATIVE RADIOTHERAPY FOR STAGE I NON SMALL CELL LUNG CANCER
    Beltramo, G.
    Bergantin, A.
    Martinotti, A.
    Bonfanti, P.
    Bianchi, L. C.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S570 - S571
  • [29] Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more
    White, Abby
    Swanson, Scott J.
    JOURNAL OF THORACIC DISEASE, 2016, 8 : S399 - S405
  • [30] Lobectomy versus Stereotactic Ablative Radiotherapy (SABR) for Stage I Non Small Cell Lung Cancer (NSCLC) in 182 Patients
    Scotti, Vieri
    Simontacchi, Gabriele
    Furfaro, Ilaria Francesca
    Scartoni, Daniele
    Gonfiotti, Alessandro
    Viggiano, Domenico
    Cardillo, Carla De Luca
    Ferrari, Katia
    Agresti, Benedetta
    Zei, Giacomo
    Perna, Marco
    Bastiani, Paolo
    Bruni, Alessio
    Voltolini, Luca
    Livi, Lorenzo
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S675 - S675
12345